Abstract Objective To study the risk factors for hypoxemia in children with severe Mycoplasma pneumoniae pneumonia (SMPP). Methods A retrospective collection of clinical data from children diagnosed with SMPP at the Third Affiliated Hospital of Zhengzhou University from June to December 2023 was conducted. The patients were categorized into hypoxemia and non-hypoxemia groups. Logistic regression analysis was used to assess the risk factors for hypoxemia, and receiver operating characteristic (ROC) curve analysis was employed to analyze the diagnostic performance of various indicators. Results A total of 113 children with SMPP were included. Univariate logistic regression analysis showed that ferritin, aspartate aminotransferase, creatinine, creatine kinase isoenzyme, lactate dehydrogenase, alpha-hydroxybutyrate dehydrogenase, immunoglobulin G, complement C3, complement C4, age, extrapulmonary complications, and a chest computed tomography (CT) scan showing a bronchiolitis pattern were significant factors for hypoxemia in children with SMPP (P<0.05). Multivariate logistic regression analysis revealed that elevated ferritin levels, presence of extrapulmonary complications, and a bronchiolitis pattern on lung CT were independent risk factors for hypoxemia in these patients (P<0.05). The ROC curve analysis indicated that the combination of these three indicators for predicting hypoxemia had a sensitivity of 71.9%, a specificity of 95.1%, and an area under the curve of 0.888 (95%CI: 0.809-0.968). Conclusions In children with SMPP, when there are elevated ferritin levels, a bronchiolitis pattern on chest CT, and the presence of extrapulmonary complications, there should be a high level of vigilance for the potential development of hypoxemia.
QIN Yu-Jie,YANG Yu-Xia,LI Jun-Xiang et al. Risk factors for hypoxemia in children with severe Mycoplasma pneumoniae pneumonia[J]. CJCP, 2025, 27(2): 192-198.
QIN Yu-Jie,YANG Yu-Xia,LI Jun-Xiang et al. Risk factors for hypoxemia in children with severe Mycoplasma pneumoniae pneumonia[J]. CJCP, 2025, 27(2): 192-198.
Guleria R, Nisar N, Chawla TC, et al. Mycoplasma pneumoniae and central nervous system complications: a review[J]. J Lab Clin Med, 2005, 146(2): 55-63. PMID: 16099235. DOI: 10.1016/j.lab.2005.04.006.
